These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 357362)

  • 1. Increased production of the antibiotic aurodox (X-5108) by aurodox-resistant mutants.
    Unowsky J; Hoppe DC
    J Antibiot (Tokyo); 1978 Jul; 31(7):662-6. PubMed ID: 357362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of resistance to aurodox by aurodox in the antibiotic-producing culture, Streptomyces goldiniensis.
    Liu CM; Hermann TE; Miller PA
    J Antibiot (Tokyo); 1979 Oct; 32(10):1025-32. PubMed ID: 118955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioconversion capacity of Streptomyces sp GE44282, a producer of the antibiotics heneicomycin and aurodox.
    Marinelli F; Stella S; Montanini N; Le Monnier F; Cavaletti L; Selva E
    J Ind Microbiol; 1995 Jul; 15(1):49-54. PubMed ID: 7662297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feedback inhibition of the synthesis of an antibiotic: aurodox (X-5108).
    Liu C; Hermann T; Miller PA
    J Antibiot (Tokyo); 1977 Mar; 30(3):244-51. PubMed ID: 405357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosynthesis of Aurodox, a Type III Secretion System Inhibitor from Streptomyces goldiniensis.
    McHugh RE; Munnoch JT; Braes RE; McKean IJW; Giard J; Taladriz-Sender A; Peschke F; Burley GA; Roe AJ; Hoskisson PA
    Appl Environ Microbiol; 2022 Aug; 88(15):e0069222. PubMed ID: 35867559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the Mode of Action of Aurodox, a Type III Secretion System Inhibitor from Streptomyces goldiniensis.
    McHugh RE; O'Boyle N; Connolly JPR; Hoskisson PA; Roe AJ
    Infect Immun; 2019 Feb; 87(2):. PubMed ID: 30455200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biosynthesis of aurodox (antibiotic X-5108). incorporation of 14C-labelled precursors into aurodox.
    Liu CM; Maehr H; Leach M; Liu M; Miller PA
    J Antibiot (Tokyo); 1977 May; 30(5):416-9. PubMed ID: 328470
    [No Abstract]   [Full Text] [Related]  

  • 8. 13C-NMR studies on the biosynthesis of aurodox (antibiotic X-5108).
    Liu CM; Williams TH; Pitcher RG
    J Antibiot (Tokyo); 1979 Apr; 32(4):414-7. PubMed ID: 381271
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibiotic SB22484: a novel complex of the aurodox group. I. Taxonomy of the producing organism, isolation of the antibiotics and chemical and biological characterization.
    Selva E; Beretta G; Pallanza R; Goldstein BP; Berti M; Edwards DM; Denaro M
    J Antibiot (Tokyo); 1990 Nov; 43(11):1349-58. PubMed ID: 2272911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome sequence of the aurodox-producing bacterium
    McHugh RE; Munnoch JT; Roe AJ; Hoskisson PA
    Access Microbiol; 2022 Aug; 4(5):acmi000358. PubMed ID: 36003359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics of mutants of Streptomyces peucetius subsp. caesius ATCC 27952 resistant to anthracycline antibiotics].
    Dubyts'ka LP; Fedorenko VO
    Mikrobiol Z; 2001; 63(4):53-61. PubMed ID: 11692678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of glucose on the antibiotic activity and antibiotic resistance of Streptomyces peucetius subsp. caesius ATCC 27952-2 and its mutants].
    Dubitskaia LP; Fedorenko VA
    Antibiot Khimioter; 2002; 47(6):7-11. PubMed ID: 12422641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of mutagenic factors on the variability of cultures of Actinomyces griseus--preducer of the antibiotic grisin].
    Iustratova LS; Kuklin VV
    Antibiotiki; 1977 Nov; 22(11):981-4. PubMed ID: 596846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Isolation and characteristics of rifampicin-resistant mutants of Streptomyces erythraeus strain].
    Nastasiak IN; Fedorenko VA; Kirichenko NV; Danilenko VN
    Antibiot Khimioter; 1990 Dec; 35(12):11-3. PubMed ID: 2078070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The structure of heneicomycin.
    Dewey RS; Hensens OD; Douglas AW; Albers-Schönberg G
    J Antibiot (Tokyo); 1991 Aug; 44(8):838-43. PubMed ID: 1917698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of Streptomyces ambofaciens mutants that produce large quantities of spiramycin and determination of optimal conditions for spiramycin production.
    Ford LM; Eaton TE; Godfrey OW
    Appl Environ Microbiol; 1990 Nov; 56(11):3511-4. PubMed ID: 2268160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oxadin effect on actinomycetes strains].
    Naidenova MM; Michaĭilov YG; Ivanova I
    Antibiot Khimioter; 2001; 46(1):7-9. PubMed ID: 11221085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A small-molecule inhibitor of the bacterial type III secretion system protects against in vivo infection with Citrobacter rodentium.
    Kimura K; Iwatsuki M; Nagai T; Matsumoto A; Takahashi Y; Shiomi K; Omura S; Abe A
    J Antibiot (Tokyo); 2011 Feb; 64(2):197-203. PubMed ID: 21139624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformation and reactivity changes induced by N-methylkirromycin (aurodox) in elongation factor Tu.
    Balestrieri C; Giovane A; Quagliuolo L; Servillo L; Chinali G
    Biochemistry; 1989 Aug; 28(17):7097-101. PubMed ID: 2510820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristics of Streptomyces kanamyceticus mutants resistant to aminoglycoside antibiotics].
    Demidchuk IuA; Golets LM; Fedorenko VA
    Antibiot Khimioter; 1996 Jun; 41(6):15-20. PubMed ID: 9054322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.